FDA approves new way to fight opioid addiction

Published



Federal regulators cleared an entirely new way to tackle opioid addiction, approving on Thursday an implant that can help treat dependence.

The Food and Drug Administration approved Probuphine, which is an implant intended to provide a low-level dose of the addiction treatment buprenorphine. The approval comes a few weeks after the House and Senate approved competing opioid bills.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.